GCC CLINICAL NURSING RESOURCE

Pancreatitis: Comprehensive Nursing Guide

Acute & Chronic Pancreatitis — Assessment, Management & GCC Context for ICU and ward nurses

Definition & Overview

Acute pancreatitis (AP) is an inflammatory condition of the pancreas caused by premature activation of digestive enzymes within the gland, leading to autodigestion and a systemic inflammatory response. It ranges from mild self-limiting disease to life-threatening multi-organ dysfunction.

Incidence: 4–45 per 100,000/year Mortality: mild <1% / severe up to 30% Most cases (80%) are mild and self-limiting

🔍 Causes — Mnemonic: IGET SMASHED

I GET SMASHED — Common Causes of Acute Pancreatitis
I Idiopathic
No identifiable cause (~10–15%)
G Gallstones
Most common cause; biliary obstruction
E Ethanol
2nd most common in West; direct toxicity
T Trauma
Blunt abdominal injury; ERCP-related
S Steroids
Azathioprine, corticosteroids
M Mumps/Infection
Viral (CMV, coxsackie, HIV)
A Autoimmune
Type 1 (IgG4-related), Type 2
S Scorpion sting
Tityus trinitatis species (Caribbean/GCC)
H Hyperlipidaemia/Hypercalcaemia
TG >11 mmol/L; hyperparathyroidism
E ERCP
Post-ERCP pancreatitis in 1–5% of cases
D Drugs
Furosemide, valproate, metronidazole, DDI
💡 In the GCC, gallstone and hypertriglyceridaemia-induced pancreatitis are the leading causes, with alcohol-induced pancreatitis being comparatively less common than Western populations.

📈 Pathophysiology

Triggering event (gallstone, alcohol, hypertriglyceridaemia)
Premature activation of trypsinogen → trypsin
Pancreatic autodigestion
Local inflammation & acinar cell death
Cytokine release (IL-1, IL-6, TNF-α)
SIRS
MODS (severe cases)
The key principle: pancreatic enzymes that should only be activated in the duodeinal lumen are prematurely activated inside the pancreas. SPINK1 gene (serine protease inhibitor) normally prevents this.

📋 Clinical Features

Symptoms

  • Epigastric pain — sudden onset, severe, constant
  • Radiation to the back (60%) — "boring" quality
  • Nausea and vomiting (90%) — not relieving pain
  • Anorexia, abdominal distension
  • Fever (38–39°C in moderate/severe)
  • Pain relief in sitting forward / knee-chest position

Signs

  • Epigastric tenderness ± guarding
  • Reduced/absent bowel sounds (ileus)
  • Jaundice (if biliary obstruction)
  • Grey Turner's sign — flank bruising (haemorrhagic)
  • Cullen's sign — periumbilical bruising (haemorrhagic)
  • Signs of shock (tachycardia, hypotension) in severe AP
  • Pleural effusion (left-sided more common)

💊 Diagnosis

Biochemical (2 of 3 criteria required for diagnosis)

  • Characteristic abdominal pain
  • Serum lipase or amylase >3× ULN
  • Characteristic imaging findings
Lipase is preferred over amylase — higher sensitivity and specificity; remains elevated longer (3–5 days vs 24h for amylase). Amylase may be normal in alcohol-induced and hypertriglyceridaemia-induced AP.

Imaging

ModalityUse
Ultrasound abdomenFirst-line; identifies gallstones, biliary dilatation
CT abdomen (contrast)Not required in mild AP; indicated if diagnosis uncertain or no improvement at 48–72h
MRCPSuspected CBD stone without need for intervention
EUSIdiopathic pancreatitis workup; microlithiasis
CT scan: avoid in first 48–72h — necrosis not yet demarcated. Ideal timing is 72–96h if needed.

Other Labs to Order

TestSignificance
FBCWBC elevation (infection/SIRS); haematocrit >44% = haemoconcentration (severity marker)
LFTs / Bilirubin / GGTBiliary aetiology if ALT >3× ULN
Serum calciumHypocalcaemia in haemorrhagic/severe AP (saponification)
Fasting lipids / TGIdentify hypertriglyceridaemia aetiology (TG >11 mmol/L)
Blood glucoseStress hyperglycaemia common; monitor closely
CRPCRP >150 at 48h = severity marker
ProcalcitoninDistinguish infected necrosis vs sterile (trending >1.8 ng/mL)

Revised Atlanta Classification (2012)

MILD AP
  • No organ failure
  • No local complications
  • No systemic complications
  • Usually resolves in 1 week
  • Mortality: <1%
MODERATELY SEVERE AP
  • Transient organ failure <48h, OR
  • Local complications, OR
  • Exacerbation of pre-existing comorbidity
  • May need HDU-level care
  • Mortality: 1–10%
SEVERE AP
  • Persistent organ failure >48h
  • Single or multi-organ
  • Respiratory / renal / cardiovascular
  • Requires ICU admission
  • Mortality: 15–30% (with necrosis up to 50%)
Organ failure defined using Modified Marshall Score: ≥2 in any of — respiratory (PaO2/FiO2), renal (creatinine), cardiovascular (systolic BP).

📈 BISAP Score

Bedside Index of Severity in Acute Pancreatitis — assessed within first 24 hours. One point each:

CriterionThresholdClinical Relevance
B — Blood Urea NitrogenBUN >25 mg/dL (8.9 mmol/L)Reflects haemoconcentration / renal hypoperfusion
I — Impaired mental statusDisorientation, confusionEncephalopathy suggests severity
S — SIRS criteria (≥2)See SIRS definitionSystemic inflammatory response
A — Age>60 yearsReduced physiological reserve
P — Pleural effusionPresent on imagingIndicates exudative inflammatory process
BISAP ≥3 = severe pancreatitis risk. In-hospital mortality: Score 0 = 0.1%, Score 3 = 5.3%, Score 4 = 12.7%, Score 5 = 22.5%

SIRS Criteria (≥2 required)

  • Temperature <36°C or >38°C
  • Heart rate >90 bpm
  • Respiratory rate >20/min or PaCO2 <32 mmHg
  • WBC <4 or >12 ×10⁹/L, or >10% bands

📋 CT Balthazar Grading (CTSI)

GradeCT FindingsCT Score
ANormal pancreas0
BPancreatic enlargement only1
CPancreatic ± peripancreatic inflammation2
DSingle extrapancreatic fluid collection3
ETwo or more fluid collections / gas in pancreas4

Necrosis Score Added to Balthazar Score = CTSI (max 10)

NecrosisAdditional Points
None0
<33%2
33–50%4
>50%6
🚫 CTSI ≥6: associated with morbidity rate 92% and mortality 17%. Requires intensive monitoring and specialist HPB team input.

🕐 Early vs Late Complications Timeline

Early Complications (within 1 week)

  • ARDS / acute respiratory failure
  • Acute kidney injury / renal failure
  • Haemodynamic shock (distributive / hypovolaemic)
  • Disseminated intravascular coagulation (DIC)
  • Acute peripancreatic fluid collections (APFC)
  • Acute necrotic collections (ANC)
  • Severe haemorrhage (erosion of peripancreatic vessels)

Late Complications (>4 weeks)

  • Pseudocyst — encapsulated fluid collection, usually sterile
  • Walled-off necrosis (WON) — mature necrotic collection
  • Infected pancreatic necrosis — most serious late complication
  • Pancreatic fistula (internal or external)
  • Splenic/portal vein thrombosis
  • New-onset diabetes mellitus
  • Exocrine pancreatic insufficiency

📌 BISAP Score Calculator

0

💧 IV Fluid Resuscitation — Priority Intervention

Hartmann's solution (Lactated Ringer's) is preferred over normal saline. Meta-analysis evidence shows Hartmann's is associated with lower rates of SIRS, systemic complications, and persistent organ failure compared to 0.9% NaCl.
1
Initial aggressive resuscitation: 250–500 ml/h Hartmann's in first 12–24h (moderate-severe AP). Bolus 500–1000ml if haemodynamically compromised.
2
Maintenance phase: 250 ml/h ongoing, guided by clinical response. Reassess every 4–6 hours.
3
Target markers: Urine output ≥0.5 ml/kg/h, HR <100 bpm, MAP >65 mmHg, haematocrit 35–44%, BUN decreasing, improving clinical status.
4
Caution: Over-resuscitation causes abdominal compartment syndrome. Goal-directed therapy with reassessment is key — more is not always better after the first 48h.
In hypertriglyceridaemia-induced pancreatitis: aggressive fluid resuscitation remains the same; additionally consider insulin infusion (activates lipoprotein lipase) and/or plasmapheresis for TG >22 mmol/L refractory to insulin.

⚙ Fluid Resuscitation Rate Guide

ml/h

🍴 Nutrition in Acute Pancreatitis

🚫 Traditional "NPO until pain resolves" is OUTDATED and harmful in severe AP. Prolonged fasting causes gut barrier disruption, bacterial translocation, and worsens outcome.

Mild AP

  • Oral fluids when tolerated, usually within 24–48h
  • Start low-fat soft diet early if no N&V
  • No benefit from prolonged NPO or nasogastric feeds
  • IV fluids for hydration while NBM if not tolerating oral

Severe AP

  • Early enteral nutrition (EN) within 24–48h — reduces infectious complications, shortens hospital stay, decreases mortality vs TPN
  • Nasojejunal (NJ) tube preferred for severe AP — bypasses pancreatic stimulation better than NG
  • NG feeding acceptable if NJ placement not immediately available — comparable outcomes per recent trials
  • TPN: only if EN not tolerated after 5–7 days trial

NJ Tube Insertion — Nursing Points

  • Confirm placement fluoroscopically or via post-pyloric tip (Treitz ligament) on X-ray before feeding
  • Start feeds at 10–20 ml/h, titrate up by 10 ml/h every 4–6h
  • Use semi-elemental or polymeric formula — equally efficacious in meta-analyses
  • Monitor for feed tolerance: abdominal distension, residuals, bowel sounds

💊 Pain Management

🚫 Meperidine (pethidine) is NO LONGER recommended as first-line analgesia despite historical preference. Its active metabolite normeperidine causes CNS toxicity/seizures, and it has no proven superiority.

Preferred Analgesia

  • IV morphine — first-line opioid; safe to use (earlier concern about sphincter of Oddi spasm was not clinically significant)
  • IV fentanyl — preferred in renal impairment (no active metabolites); can be given as PCA
  • Hydromorphone — alternative opioid option
  • Paracetamol IV (acetaminophen) — adjunct for mild/moderate pain
  • Epidural analgesia — consider in severe AP with complex pain management

Nursing Monitoring

  • Pain score assessment Q2–4h (NRS 0–10)
  • Monitor for opioid side effects: respiratory depression, sedation, ileus
  • Positioning: semi-recumbent or foetal position for comfort
  • Avoid NSAIDs if AKI present
  • Document pain trend — worsening pain may indicate complication

📋 Monitoring Parameters

ParameterTarget / ConcernFrequency
Urine output (IDC mandatory)≥0.5 ml/kg/h; oliguria = alarmingHourly in severe AP
Blood glucose (BGL)Target 6–10 mmol/L; stress hyperglycaemia commonQ4–6h; insulin PRN
Serum calciumHypocalcaemia in haemorrhagic AP; replace if <2.0 mmol/LDaily in severe AP
Vital signs / NEWS2HR, BP, RR, SpO2, TemperatureQ1–4h depending on severity
Fluid balance (strict)Target neutral to slight positive initially; avoid fluid overloadHourly ins & outs
Respiratory status / SpO2ARDS risk; supplemental O2 if SpO2 <94%Continuous monitoring in severe AP
Abdomen (girth/tenderness)Increasing girth = abdominal compartment syndromeQ8h girth measurement
Mental status / GCSEncephalopathy indicates severityQ4h
Intra-abdominal pressure (IAP) measurement: if abdominal compartment syndrome suspected (IAP >20 mmHg + organ failure), urgent surgical consult. Measure IAP via IDC bladder pressure.

📌 Pancreatic Pseudocyst

Definition & Timing

  • Encapsulated collection of pancreatic fluid (amylase-rich)
  • No solid component (differentiates from WON)
  • Forms ≥4 weeks after acute pancreatitis
  • Majority resolve spontaneously (up to 40–50%)

Clinical Features

  • Persistent abdominal pain, early satiety, nausea
  • Palpable epigastric mass (large pseudocysts)
  • Persistently elevated serum amylase/lipase
  • Confirmed on CT/MRI or EUS

Management Algorithm

1
Wait 4–6 weeks for wall maturation before any intervention
2
Endoscopic drainage (EUS-guided) — preferred approach for symptomatic/expanding pseudocysts adjacent to stomach or duodenum
3
Surgical cystgastrostomy or cystjejunostomy — if endoscopic approach fails or anatomy unfavourable
4
Antibiotics only if pseudocyst becomes infected (aspiration / culture confirming)

🚫 Infected Pancreatic Necrosis — Most Critical Complication

Infected necrosis develops in 30–40% of patients with necrotising pancreatitis and carries mortality up to 30–40%. KEY indicator: new fever or clinical deterioration after initial improvement, typically >7–10 days into admission.

Diagnosis

  • Fever spike after initial improvement (>7–10 days)
  • Rising CRP / procalcitonin >1.8 ng/mL
  • CT: gas bubbles within necrosis (pathognomonic)
  • CT-guided Fine Needle Aspiration (FNA) for Gram stain + culture (now less favoured with improved CT/procalcitonin accuracy)

Organisms

  • Gram-negative bacteria most common: E.coli, Klebsiella, Pseudomonas
  • Gram-positive: Staphylococcus, Enterococcus
  • Fungal (Candida) in prolonged ICU stay / broad-spectrum antibiotics

Step-Up Management Approach

1
Broad-spectrum antibiotics: Carbapenem (meropenem/imipenem) — best pancreatic tissue penetration; alternatively piperacillin-tazobactam
2
Radiological drainage (step 1): Percutaneous CT-guided drain — may be definitive in some cases; provides source control and cultures
3
Video-Assisted Retroperitoneal Debridement (VARD) — minimally invasive endoscopic/laparoscopic necrosectomy
4
Open necrosectomy — reserved for failure of above; highest morbidity and mortality; avoid in first 3–4 weeks
Prophylactic antibiotics in sterile necrosis are NOT routinely recommended (Cochrane review 2010 confirms no benefit).

📋 Post-ERCP Pancreatitis Prevention

Post-ERCP pancreatitis (PEP) occurs in 1–5% of procedures and up to 15–25% in high-risk patients. It is the most common serious complication of ERCP.

Prevention Strategies

  • Rectal indomethacin 100mg — STRONGLY recommended for all patients undergoing ERCP (NNT = 13); administer immediately before or after procedure
  • Prophylactic pancreatic stent — in high-risk cases (prior PEP, difficult cannulation, sphincter of Oddi dysfunction, pancreatic duct manipulation)
  • Adequate hydration: aggressive IV Hartmann's peri-procedure
  • Wire-guided cannulation preferred over contrast injection

Nursing Observations Post-ERCP

  • Monitor for abdominal pain onset within 2–4h post-procedure
  • Check lipase/amylase at 2–4h if pain develops
  • Monitor vital signs Q1h for first 4h
  • Keep NBM until alert and no pain
  • Document: time of procedure, stent placed (Y/N), indomethacin given (Y/N)
  • Ensure rectal indomethacin was administered — verify on drug chart

Biliary Pancreatitis — Cholecystectomy Timing

Cholecystectomy should be performed during the same admission for mild biliary pancreatitis, or within 2 weeks of discharge. Delayed cholecystectomy is associated with 18% recurrence risk within 30 days.
AP SeverityRecommended TimingRationale
Mild biliary APSame admission (within 7 days)Prevents recurrence; safe, reduces readmission
Moderate biliary APAfter full recovery; within 3–6 weeksAllow local inflammation to settle
Severe biliary AP with necrosisDefer 6+ weeks; manage necrosis firstPremature surgery increases mortality

Nursing Role Pre-Cholecystectomy

  • Ensure CBD clearance documented (MRCP or ERCP if CBD stones present)
  • Anaesthetic review completed
  • Patient counselled on laparoscopic vs open risk
  • Mark site, consent obtained, correct fasting status

📈 Chronic Pancreatitis — Overview & Causes

Chronic pancreatitis is a progressive inflammatory disorder with irreversible morphological changes resulting in permanent loss of exocrine and endocrine pancreatic function.

Causes (TIGAR-O Classification)

  • Alcohol — 70–80% in Western countries; men 35–45 years
  • Idiopathic — 20%; early-onset (juvenile) and late-onset forms
  • Hereditary / Genetic — SPINK1 (serine protease inhibitor), CFTR mutations (cystic fibrosis), PRSS1 gene (hereditary pancreatitis)
  • Autoimmune — Type 1 (IgG4) responds to steroids
  • Recurrent acute pancreatitis — repeated bouts lead to fibrosis
  • Obstruction — pancreatic duct stricture, trauma, periampullary tumours
  • Tropical pancreatitis — fibro-calculous (southern Asia; cassava toxin hypothesis)

Pathological Changes

  • Progressive pancreatic fibrosis
  • Ductal distortion and strictures (chain of lakes)
  • Pancreatic calcifications (visible on plain AXR)
  • Loss of acinar cells → exocrine insufficiency
  • Loss of islet cells → endocrine insufficiency
  • Intraductal stones (pancreatic calculi)
Pancreatic adenocarcinoma risk is 4–20× elevated in chronic pancreatitis. Surveillance discussion warranted for hereditary/prolonged cases.

📋 Clinical Features

Pain

  • Chronic, recurring epigastric pain — often severe
  • Radiates to back; worsened by eating
  • Two patterns: intermittent painful episodes vs constant pain
  • Up to 15% are pain-free despite significant insufficiency

Exocrine Insufficiency (EPI)

  • Occurs when >90% exocrine function lost
  • Steatorrhoea — oily, foul-smelling, floating stools
  • Weight loss, malabsorption
  • Fat-soluble vitamin deficiency (A, D, E, K)
  • Diagnosed by faecal elastase-1 <200 μg/g stool

Endocrine Insufficiency — Type 3c Diabetes (T3cDM)

  • Pancreatogenic diabetes — distinct from T1DM and T2DM
  • Loss of both alpha cells (glucagon) and beta cells (insulin)
  • Results in brittle, hypoglycaemia-prone diabetes
  • Often requires insulin but highly sensitive to it
  • Treat: insulin (cautiously), SGLT2 inhibitors investigated
  • Metformin can be used but GI side effects problematic
🚫 T3cDM patients are at high hypoglycaemia risk — no glucagon counter-regulation. Close BGL monitoring essential.

💊 Pancreatic Enzyme Replacement Therapy (PERT) — CREON

Indications for PERT

  • Steatorrhoea confirmed clinically or by faecal elastase <100 μg/g
  • Weight loss despite adequate caloric intake
  • Confirmed exocrine pancreatic insufficiency

CREON Dosing

  • Initial dose: 25,000–40,000 lipase units per main meal
  • Snacks: half the meal dose
  • Max: 75,000–80,000 lipase units per meal
  • Titrate upward based on stool normalisation
  • Must be taken with food (or within 30 min of starting meal)

Nursing Education Points for PERT

  • Take capsules with every meal and snack
  • Swallow whole — do not crush (if unable: open capsule, sprinkle on acidic food like applesauce)
  • Do NOT heat or mix with hot food (destroys enzymes)
  • Monitor stool frequency and character (steatorrhoea improvement)
  • Weight monitoring monthly
  • Report if no improvement in 4–6 weeks (reassess dose or compliance)

Fat-Soluble Vitamin Supplementation

  • Vitamins A, D, E, K — supplement routinely with EPI
  • Check levels annually (25-OH vitamin D, PT for vitamin K)
  • Vitamin D deficiency extremely common in GCC chronic pancreatitis patients

💃 Pain Management in Chronic Pancreatitis

1
Lifestyle: Strict alcohol abstinence (slows progression, reduces pain in alcohol-related CP), smoking cessation, low-fat diet
2
Analgesia ladder: Paracetamol → Tramadol → Opioids (with caution for addiction). Pregabalin/Gabapentin for neuropathic component.
3
Endoscopic therapy: ESWL (extracorporeal shockwave lithotripsy) for pancreatic duct stones → endoscopic clearance; stenting of strictures
4
Coeliac plexus block / neurolysis: EUS-guided; 50–60% achieve temporary pain relief. Effect lasts months.
5
Surgery: Puestow procedure (lateral pancreaticojejunostomy — for dilated ducts ≥6mm), Frey procedure (duct drainage + head coring), Whipple (pancreaticoduodenectomy — for head-dominant disease or cancer concern)
Total pancreatectomy with islet autotransplantation (TPIAT) — considered for hereditary/paediatric CP with refractory pain. Specialist centre only.

🌍 GCC Epidemiology of Pancreatitis

~65%
AP cases in GCC from gallstones
~15%
Hypertriglyceridaemia-induced AP
<5%
Alcohol-induced (lower than West)
40–50%
GCC women affected by cholelithiasis
The GCC region has one of the highest cholelithiasis rates globally, driven by obesity, rapid weight loss (bariatric surgery), oral contraceptive use, and sedentary lifestyles — all contributing to high gallstone pancreatitis prevalence.

📅 Hypertriglyceridaemia-Induced Pancreatitis in GCC

Risk Factors in GCC Population

  • High saturated fat dietary patterns
  • High prevalence of uncontrolled T2DM (>20% in some GCC countries)
  • Low physical activity / obesity epidemic
  • Familial hypertriglyceridaemia (common in consanguineous populations)
  • Alcohol-TG interaction in non-Muslim expatriate population
  • Hypothyroidism (undertreated) can elevate TG

Management Specifics

  • Threshold for HTG pancreatitis: TG >11 mmol/L (1,000 mg/dL)
  • IV insulin infusion: activates lipoprotein lipase → rapid TG reduction
  • IV dextrose: concurrent with insulin to prevent hypoglycaemia in normoglycaemic patients
  • Plasmapheresis: for TG >22 mmol/L or refractory to insulin; available at tertiary GCC centres
  • Target TG <5.6 mmol/L before discharge
  • Fibrates on discharge; referral to lipid clinic

Acute Pancreatitis During Ramadan

A notable seasonal pattern of acute pancreatitis is observed in GCC hospitals during Ramadan months, driven by specific physiological and dietary behaviours.

Ramadan-Specific Risk Factors

  • Dehydration: 12–18h fasting without fluids → haemoconcentration → gallstone mobilisation
  • Large meals at Iftar → rapid gallbladder contraction → stone impaction
  • High-fat Iftar meals → cholecystokinin surge → gallbladder contraction
  • Altered medication timing → missed lipid-lowering drugs → TG surge
  • Irregular sleep/wake cycle → altered GI motility

Nursing Considerations During Ramadan

  • Offer IV fluid resuscitation promptly — patient may be severely dehydrated on admission
  • Clarify fasting status and last oral intake carefully
  • Coordinate medication timing with religious observance — consult with patient and Islamic scholar if needed
  • Dietary counselling: low-fat Iftar and Suhoor meals for cholelithiasis patients
  • Cultural sensitivity: hospitalised patients are generally exempt from fasting; explain this compassionately

🏠 Leading HPB Centres in GCC

CentreCountryKey Capabilities
Sheikh Khalifa Medical City (SKMC)UAE (Abu Dhabi)Advanced endoscopy, minimally invasive HPB surgery, ERCP, EUS-guided procedures
Hamad Medical CorporationQatar (Doha)Hepatobiliary surgery, liver transplant, advanced ERCP, interventional radiology
American Hospital DubaiUAE (Dubai)Laparoscopic HPB surgery, ERCP, endoscopic necrosectomy
King Faisal Specialist Hospital & Research CentreKSA (Riyadh)Liver transplant, complex HPB, ERCP, pancreatic surgery
Cleveland Clinic Abu DhabiUAE (Abu Dhabi)Multidisciplinary HPB, ERCP, endoscopic ultrasound, complex pancreatitis
GCC nurses should be familiar with the regional transfer pathway for severe pancreatitis requiring specialist intervention (endoscopic necrosectomy, VARD, plasmapheresis, TPIAT).

📋 GCC ICU Management Pearls

  • Early gastroenterology AND general surgery / HPB surgery co-management for moderate-severe AP
  • Intensivist-led care in ICU with APACHE-II scoring on admission
  • Liaison with dietary team early for EN planning (NJ tube placement within 24h of ICU admission)
  • Pharmacist review: ensure rectal indomethacin prescribing for post-ERCP patients
  • Family communication: GCC family structures mean extensive family meetings — involve interpreter as needed
  • Infection control: Carbapenem stewardship — consult ID team before prolonged antibiotic therapy in infected necrosis
  • Diabetic pancreatitis: ensure endocrinology review for new-onset hyperglycaemia or worsening T3cDM

❓ Practice MCQs — Self Assessment

10 clinical questions covering key pancreatitis nursing concepts. Instant feedback provided.

Score: 0 / 0 answered
QUESTION 1 of 10
A 45-year-old woman presents with sudden-onset epigastric pain radiating to the back, serum lipase 1,200 U/L (normal <60), and ultrasound showing gallstones. Her vitals show HR 105 bpm, RR 22/min, temperature 38.5°C. What is the MOST appropriate initial IV fluid?
QUESTION 2 of 10
According to the Revised Atlanta Classification, which of the following defines SEVERE acute pancreatitis?
QUESTION 3 of 10
A patient with severe acute pancreatitis is admitted to the ICU. Their BISAP score is 4. Which component is NOT part of the BISAP score?
QUESTION 4 of 10
A patient with biliary acute pancreatitis recovers fully. What is the recommended timing for cholecystectomy to prevent recurrence?
QUESTION 5 of 10
A nurse is caring for a patient with acute pancreatitis who is NPO. On day 3, the patient is intubated in the ICU with severe pancreatitis. Regarding nutrition, what should be initiated?
QUESTION 6 of 10
A patient with chronic pancreatitis due to alcohol use has steatorrhoea and weight loss. Faecal elastase is 80 μg/g. Which management is MOST appropriate?
QUESTION 7 of 10
In the GCC region, what is the MOST common cause of acute pancreatitis compared to Western countries?
QUESTION 8 of 10
Grey Turner's sign and Cullen's sign are late clinical findings in acute pancreatitis. What do they indicate?
QUESTION 9 of 10
A patient undergoes ERCP for choledocholithiasis. To prevent post-ERCP pancreatitis, which intervention has the strongest evidence base and is recommended for ALL patients?
QUESTION 10 of 10
A patient with severe acute pancreatitis develops new fever and clinical deterioration on day 10 of admission after initial improvement. CT shows gas bubbles within the pancreatic necrosis. What is the FIRST-LINE antibiotic choice and preferred management approach?